Logo.jpg
Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets
23. August 2022 10:54 ET | Antisense Therapeutics Limited
World first study utilizing Somalogic SomaScan® assay# to assess up to 7,000 plasma proteins in Long COVID-19 patients has elucidated novel blood markers as potential diagnostic and therapeutic...
Logo.jpg
Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets
22. August 2022 07:40 ET | Antisense Therapeutics Limited
World first study utilizing Somalogic SomaScan® assay# to assess up to 7,000 plasma proteins in Long COVID-19 patients has elucidated novel blood markers as potential diagnostic and therapeutic...
Logo.jpg
Antisense Therapeutics to present poster at world’s largest NMD conference
09. März 2022 15:01 ET | Antisense Therapeutics Limited
New York, NY, March 09, 2022 (GLOBE NEWSWIRE) -- Antisense Therapeutics Limited [ASX: ANP | US OTC: ATHJY | FSE: AWY] will deliver a virtual presentation on its antisense drug at the Muscular...